Editorial: Contemporary Perspective on 5-HT2C Receptor Function and Its Pharmacological Targeting

• Philippe De Deurwaerdère,
• Abdeslam Chagraoui,
• Abdeslam Chagraoui,
• Kathryn A. Cunningham

Affiliations

Philippe De Deurwaerdère

Institut des Neurosciences Cognitives et Integratives d’Aquitaine, CNRS UMR 5287, Bordeaux, France

Abdeslam Chagraoui

Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Institute for Research and Innovation in Biomedicine of Normandy (IRIB), Normandie University, UNIROUEN, INSERM, U1239, Rouen, France

Abdeslam Chagraoui

CHU Rouen, Rouen, France

Kathryn A. Cunningham

Center for Addiction Research and Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, United States